1. [P4–575]: ALZ‐801 MECHANISM OF ACTION: STOICHIOMETRY OF BETA AMYLOID ANTI‐OLIGOMER EFFECT, PK/PD, AND CLINICAL DOSE SELECTION FOR CONFIRMATORY PHASE 3 PROGRAM IN ALZHEIMER's DISEASE. (1st July 2017) Authors: Hey, John; Kocis, Petr; Abushakra, Susan; Yu, Jeremy; Power, Aidan; Blennow, Kaj; Tolar, Martin Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 32 Page Start: P1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P4–585]: NOVEL ENVELOPING MECHANISM OF ACTION OF ALZ‐801: CONFORMATIONAL STABILIZATION OF BETA AMYLOID BY A SMALL MOLECULE RESULTS IN ANTI‐OLIGOMER ACTIVITY. (1st July 2017) Authors: Kocis, Petr; Tolar, Martin; Blennow, Kaj; Fillit, Howard M.; Hey, John Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 32 Page Start: P1578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1‐043: INHIBITION OF AMYLOID OLIGOMER FORMATION BY ENDOGENOUS METABOLITE OF ALZ‐801/TRAMIPROSATE IN THE HUMAN BRAIN: DISCOVERY AND CHARACTERIZATION OF 3‐SPA IN NORMAL SUBJECTS AND ALZHEIMER'S DISEASE PATIENTS. (1st July 2019) Authors: Hey, John; Tolar, Martin; Abushakra, Susan; Power, Aidan; Yu, Jeremy; Kocis, Petr; Vyhnalek, Martin; Hort, Jakub Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗